Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,282.40
(
0.00%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
109.78
(
1.53%
)
Bitcoin
68,313.99
(
0.70%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: projectchris post# 125591

Wednesday, 08/24/2011 12:27:26 PM

Wednesday, August 24, 2011 12:27:26 PM

Post# of 257269
Thanks for finding that.

I really don't see reduced osteoclastic activity in late-stage patients without known bone mets as concerning at all. It's cerainly plausible these patients have occult bone mets which haven't yet shown up on a scint scan. Be nice to know if their pre-treatment CTx levels were elevated.

http://journals.lww.com/corr/Abstract/2003/10001/Diagnosis_of_Occult_Bone_Metastases__Positron.16.aspx

Peter


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today